Accessibility StatementResourcesInvestor RelationsJournalistsAgenciesClient LoginSend a ReleaseNewsProductsContactBrowse News ReleasesAll News ReleasesAll Public CompanyEnglish-onlyNews Releases OverviewMultimedia GalleryAll MultimediaAll PhotosAll VideosMultimedia Gallery OverviewTrending TopicsAll Trending TopicsAuto & TransportationAll Automotive & TransportationAerospace, DefenseAir FreightAirlines & AviationAutomotiveMaritime & ShipbuildingRailroads and Intermodal TransportationSupply Chain/LogisticsTransportation, Trucking & RailroadTravelTrucking and Road TransportationAuto & Transportation OverviewView All Auto & TransportationBusiness TechnologyAll Business TechnologyBlockchainBroadcast TechComputer & ElectronicsComputer HardwareComputer SoftwareData AnalyticsElectronic CommerceElectronic ComponentsElectronic Design AutomationFinancial TechnologyHigh Tech SecurityInternet TechnologyNanotechnologyNetworksPeripheralsSemiconductorsBusiness Technology OverviewView All Business TechnologyEntertainment & MediaAll Entertainment & MediaAdvertisingArtBooksEntertainmentFilm and Motion PictureMagazinesMusicPublishing & Information ServicesRadio & PodcastTelevisionEntertainment & Media OverviewView All Entertainment & MediaFinancial Services & InvestingAll Financial Services & InvestingAccounting News & IssuesAcquisitions, Mergers and TakeoversBanking & Financial ServicesBankruptcyBond & Stock RatingsConference Call AnnouncementsContractsCryptocurrencyDividendsEarningsEarnings Forecasts & ProjectionsFinancing AgreementsInsuranceInvestments OpinionsJoint VenturesMutual FundsPrivate PlacementReal EstateRestructuring & RecapitalizationSales ReportsShareholder ActivismShareholder MeetingsStock OfferingStock SplitVenture CapitalFinancial Services & Investing OverviewView All Financial Services & InvestingGeneral BusinessAll General BusinessAwardsCommercial Real EstateCorporate ExpansionEarningsEnvironmental, Social and Governance (ESG)Human Resource & Workforce ManagementLicensingNew Products & ServicesObituariesOutsourcing BusinessesOverseas Real Estate (non-US)Personnel AnnouncementsReal Estate TransactionsResidential Real EstateSmall Business ServicesSocially Responsible InvestingSurveys, Polls and ResearchTrade Show NewsGeneral Business OverviewView All General BusinessConsumer TechnologyAll Consumer TechnologyArtificial IntelligenceBlockchainCloud Computing/Internet of ThingsComputer ElectronicsComputer HardwareComputer SoftwareConsumer ElectronicsCryptocurrencyData AnalyticsElectronic CommerceElectronic GamingFinancial TechnologyMobile EntertainmentMultimedia & InternetPeripheralsSocial MediaSTEM (Science, Tech, Engineering, Math)Supply Chain/LogisticsWireless CommunicationsConsumer Technology OverviewView All Consumer TechnologyEnergy & Natural ResourcesAll EnergyAlternative EnergiesChemicalElectrical UtilitiesGasGeneral ManufacturingMiningMining & MetalsOil & EnergyOil and Gas DiscoveriesUtilitiesWater UtilitiesEnergy & Natural Resources OverviewView All Energy & Natural ResourcesEnvironmentAll EnvironmentConservation & RecyclingEnvironmental IssuesEnvironmental PolicyEnvironmental Products & ServicesGreen TechnologyNatural DisastersEnvironment OverviewView All EnvironmentHeavy Industry & ManufacturingAll Heavy Industry & ManufacturingAerospace & DefenseAgricultureChemicalConstruction & BuildingGeneral ManufacturingHVAC (Heating, Ventilation and Air-Conditioning)MachineryMachine Tools, Metalworking and MetallurgyMiningMining & MetalsPaper, Forest Products & ContainersPrecious MetalsTextilesTobaccoHeavy Industry & Manufacturing OverviewView All Heavy Industry & ManufacturingTelecommunicationsAll TelecommunicationsCarriers and ServicesMobile EntertainmentNetworksPeripheralsTelecommunications EquipmentTelecommunications IndustryVoIP (Voice over Internet Protocol)Wireless CommunicationsTelecommunications OverviewView All TelecommunicationsConsumer Products & RetailAll Consumer Products & RetailAnimals & PetsBeers, Wines and SpiritsBeveragesBridal ServicesCannabisCosmetics and Personal CareFashionFood & BeveragesFurniture and FurnishingsHome ImprovementHousehold, Consumer & CosmeticsHousehold ProductsJewelryNon-Alcoholic BeveragesOffice ProductsOrganic FoodProduct RecallsRestaurantsRetailSupermarketsToysConsumer Products & Retail OverviewView All Consumer Products & RetailEntertainment & MediaAll Entertainment & MediaAdvertisingArtBooksEntertainmentFilm and Motion PictureMagazinesMusicPublishing & Information ServicesRadio & PodcastTelevisionEntertainment & Media OverviewView All Entertainment & MediaHealthAll HealthBiometricsBiotechnologyClinical Trials & Medical DiscoveriesDentistryFDA ApprovalFitness/WellnessHealth Care & HospitalsHealth InsuranceInfection ControlInternational Medical ApprovalMedical EquipmentMedical PharmaceuticalsMental HealthPharmaceuticalsSupplementary MedicineHealth OverviewView All HealthSportsAll SportsGeneral SportsOutdoors, Camping & HikingSporting EventsSports Equipment & AccessoriesSports OverviewView All SportsTravelAll TravelAmusement Parks and Tourist AttractionsGambling & CasinosHotels and ResortsLeisure & TourismOutdoors, Camping & HikingPassenger AviationTravel IndustryTravel OverviewView All TravelPolicy & Public InterestAll Policy & Public InterestAdvocacy Group OpinionAnimal WelfareCongressional & Presidential CampaignsCorporate Social ResponsibilityDomestic PolicyEconomic News, Trends, AnalysisEducationEnvironmentalEuropean GovernmentFDA ApprovalFederal and State LegislationFederal Executive Branch & AgencyForeign Policy & International AffairsHomeland SecurityLabor & UnionLegal IssuesNatural DisastersNot For ProfitPatent LawPublic SafetyTrade PolicyU.S. State PolicyPolicy & Public Interest OverviewView All Policy & Public InterestPeople & CultureAll People & CultureAboriginal, First Nations & Native AmericanAfrican AmericanAsian AmericanChildrenDiversity, Equity & InclusionHispanicLesbian, Gay & BisexualMen's InterestPeople with DisabilitiesReligionSenior CitizensVeteransWomenPeople & Culture OverviewView All People & CultureArabicespañolportuguêsČeskoDanmarkDeutschlandEspañaFranceItaliaNederlandNorgePolskaPortugalРоссияSlovenskoSuomiSverigeExplore Our PlatformPlan CampaignsCreate with AIDistribute Press ReleasesReport ResultsAmplify ContentAll ProductsGeneral InquiriesEditorial BureausPartnershipsMedia InquiriesWorldwide OfficesSend a ReleaseALL CONTACT INFOContact UsSend a ReleaseClient LoginResourcesBlogJournalistsRSSBrowse All NewsMultimedia GalleryTrending TopicsAuto & TransportationBusiness TechnologyEntertainment & MediaFinancial Services & InvestingGeneral BusinessConsumer TechnologyEnergy & Natural ResourcesEnvironmentHeavy Industry & ManufacturingTelecommunicationsConsumer Products & RetailEntertainment & MediaHealthSportsTravelPeople & CultureSend a ReleaseClient LoginResourcesBlogJournalistsRSSExplore Our PlatformPlan CampaignsCreate with AIDistribute Press ReleasesReport ResultsAmplify ContentAll ProductsSend a ReleaseClient LoginResourcesBlogJournalistsRSSGeneral InquiriesEditorial BureausPartnershipsMedia InquiriesWorldwide OfficesSend a ReleaseClient LoginResourcesBlogJournalistsRSSJun 17, 2026, 11:56 ET
Lupin Launches Azilsartan Medoxomil Tablets in the United States
Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of...Jun 16, 2026, 09:00 ET
AMDI™ Fast PCR System Receives FDA 510(k) Clearance and CLIA Waiver for Sub-10-Minute Respiratory Panel
Autonomous Medical Devices Incorporated (AMDI) today announced that the U.S. Food and Drug Administration has granted both 510(k) clearance and CLIA...Jun 16, 2026, 08:00 ET
Allergan Aesthetics Receives U.S. FDA Approval for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the U.S. Food and Drug Administration (FDA) approval of SKINVIVE by JUVÉDERM® to ...Jun 16, 2026, 08:00 ET
Mighty Therapeutics, Formerly Stealth BioTherapeutics, Announces New Name Honoring the Mitochondrial Disease Community
Stealth BioTherapeutics Holdings Inc., a commercial-stage biotechnology company focused on the discovery, development, and commercialization of novel ...Jun 15, 2026, 10:25 ET
SK Life Science, Inc. Announces FDA Acceptance for Review of New Drug Application for Cenobamate Oral Suspension
SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., today announced that the U.S. Food and Drug Administration (FDA) has accepted ...Jun 15, 2026, 09:15 ET
Inhibrx Announces U.S. FDA Acceptance of BLA for Ozekibart in Patients with Conventional Chondrosarcoma
Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing novel...Jun 15, 2026, 08:00 ET
FDA grants Monoamine Oxidase Deficiency Orphan Drug Designation
Families affected by monoamine oxidase deficiency (MAOD), a rare neurodevelopmental disorder, have historically faced delayed diagnosis, limited...Jun 15, 2026, 08:00 ET
Halia Therapeutics Receives FDA Fast Track Designation for Ofirnoflast (HT-6184) in Lower-Risk Myelodysplastic Syndromes
Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company developing first-in-class therapies targeting inflammasome-driven disease...Jun 12, 2026, 20:49 ET
Breakthrough T1D Celebrates Approval of Tzield for use in Stage 3 Type 1 Diabetes in the US
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, applauds today's decision from the U.S. Food and Drug...Jun 12, 2026, 09:00 ET
Braeburn to Present Research at CPDD 2026 Annual Meeting, Including Data on Withdrawal Suppression and Real-World Treatment Retention in Patients With Opioid Use Disorder
Braeburn today announced it will present two oral presentations and two posters at the 88th Annual Scientific Meeting of the College on Problems of...Jun 11, 2026, 16:05 ET
Penumbra's THUNDERBOLT Receives FDA Clearance - Bringing Computer Assisted Vacuum Thrombectomy Technology to Stroke
Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced it has received U.S. Food and Drug Administration (FDA) clearance for ...Jun 11, 2026, 13:22 ET
Certified Group Announces FDA Acceptance of PFAS Testing Method for Seafood Matrices
Certified Group today announced that FDA has accepted the company's validated method for the analysis of perfluorooctanoic acid (PFOA) and...Jun 11, 2026, 10:01 ET
OxiWear Announces Medicare and Insurance Coverage Expansion for Continuous Oxygen Measuring Device
OxiWear, the FDA-cleared wearable medical device company dedicated to protecting patients with hypoxia, today announced that eligible patients may...Jun 11, 2026, 09:02 ET
Northern Virginia Oral Surgeons Introduce Narcotic-Free Wisdom Teeth Removal
Davary & Smith Oral & Maxillofacial Surgery, a specialty oral surgery practice serving Loudoun County and Northern Virginia, has announced a...Jun 11, 2026, 08:00 ET
Wave Neuroscience Announces FDA Clearance of MeRT® for PTSD
Wave Neuroscience, in partnership with the Texas A&M Health Institute of Biosciences and Technology, today announced that the U.S. Food and Drug...Jun 10, 2026, 09:25 ET
Matter Bio Announces FDA Clearance of IND Application for LM-LLO-TT in Pancreatic Ductal Adenocarcinoma
Matter Bio, a biotechnology company developing next-generation immunotherapies for difficult-to-treat cancers, today announced that the U.S. Food and ...Jun 10, 2026, 06:40 ET
Subtle Medical Receives FDA Clearance for SubtleHD™(CT), Expanding AI-Powered Image Enhancement into CT Imaging
Subtle Medical, a leader in AI-powered medical imaging software, today announced FDA clearance for SubtleHD™(CT), an AI-powered image enhancement...Jun 09, 2026, 18:18 ET
FDA approves Lilly's EBGLYSS® (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) approved a regimen of one maintenance dose every...Jun 09, 2026, 08:34 ET
PEPPER Introduces the Muscle Activation Suit Built to Make Strength Training Smarter and More Accessible
PEPPER, a wearable fitness company, today announced its official U.S. launch with the introduction of its FDA-cleared Muscle Activation Suit,...Jun 09, 2026, 08:28 ET
SpinaFX Medical receives FDA Investigational Device Exemption (IDE) for Triojection®, its Breakthrough, Minimally-Invasive, Image-Guided Lumbar Disc Treatment.
The prospective, randomized, multicenter trial will compare intradiscal ozone/oxygen injection plus nerve root block to nerve root block alone in 300 ...Jun 09, 2026, 03:10 ET
Pentixapharm Announces FDA Clearance of IND for Phase 3 PANDA Study of First-in-Class Cardiovascular Diagnostic Program
Pentixapharm Holding AG (Frankfurt Prime Standard: PTP), a clinical-stage biotech developing novel radiopharmaceuticals, today announced that the U.S....Jun 09, 2026, 03:06 ET
Pentixapharm Holding AG: FDA grants "Study May Proceed" for Phase 3 Study; Intended Capital Increase with Subscription Rights of up to 10 Million Shares; BaFin Financial Reporting Enforcement Review of the 2024 Consolidated Financial Statements
Pentixapharm Holding AG: FDA grants "Study May Proceed" for PANDA Phase 3 Study; Intended Capital Increase with Subscription Rights in a Volume of Up ...Jun 09, 2026, 01:07 ET
LE STENT VEINEUX GORE® VIABAHN® FORTEGRA REÇOIT L'APPROBATION DU MDR
W. L. Gore & Associates Medical Products (Gore) a annoncé aujourd'hui l'obtention du marquage CE pour le stent veineux GORE®VIABAHN®FORTEGRA, indiqué ...Jun 09, 2026, 01:07 ET
El stent venoso GORE® VIABAHN® FORTEGRA recibe aprobación MDR
W. L. Gore & Associates Medical Products (Gore) anunció hoy la aprobación de la marca CE para el stent venoso GORE® VIABAHN® FORTEGRA, indicado para...Jun 09, 2026, 01:07 ET
DER VENENSTENT GORE® VIABAHN® FORTEGRA ERHÄLT DIE MDR-ZULASSUNG
W. L. Gore & Associates Medical Products (Gore) gab heute die CE-Zulassung für den GORE®VIABAHN®FORTEGRA Venenstent bekannt, der für die Behandlung...GET STARTEDPR Newswire for JournalistsSubmit a free ProfNet requestLEARN MOREGeneral InquiriesEditorial BureausPartnershipsMedia InquiriesWorldwide OfficesFor MarketersFor Public RelationsFor IR & ComplianceFor AgencyAll ProductsAbout PR NewswireAbout CisionBecome a Publishing PartnerBecome a Channel PartnerCareersAccessibility StatementAPACAPAC - Simplified ChineseAPAC - Traditional ChineseBrazilCanadaCzechDenmarkFinlandFranceGermanyIndiaIndonesiaIsraelItalyJapanKoreaMexicoMiddle EastMiddle East - ArabicNetherlandsNorwayPolandPortugalRussiaSlovakiaSpainSwedenUnited KingdomVietnamAll New ReleasesPlatform LoginProfNetData PrivacyDo not sell or share my personal information[email protected]Contact PR NewswireProductsAboutAll News ReleasesPlatform LoginProfNetTerms of UsePrivacy PolicyInformation Security PolicySite MapRSSCookiesCision
All FDA Approval News and Press Releases from PR Newswire,AI智能索引,全网链接索引,智能导航,网页索引
- All FDA Approval News and Press Releases from PR Newswire - 提供全网公开链接智能索引服务，快速访问目标内容，支持分类筛选和智能导航